456
Views
6
CrossRef citations to date
0
Altmetric
Transformations in Cancer Care: Values, Limits, Subjectivities

Game-changing? When Biomarker Discovery and Novel Forms of Patient Work Meet

ORCID Icon

References

  • Andre, T., K. Shiu, T. Kim, B. Jensen, L. Jensen, C. Punt, D. Smith, et al. 2020 Pembrolizumab versus chemotherapy for microsatellite instability- high/mismatch repair deficient metastatic colorectal cancer: The phase 3 KEYNOTE-177 study. Journal of Clinical Oncology 38(18_suppl). doi:10.1200/JCO.2020.38.18_suppl.LBA4.
  • Arney, K. 2020 Rebel Cell: Cancer, Evolution and the Science of Life. London: Weidenfeld and Nicolson.
  • Arteaga, I. 2018 Life must go on: Everyday experiences of colorectal cancer in London. PhD dissertation, Department of Anthropology, University College London.
  • Arteaga, I. 2020 Emotion work during colorectal cancer treatments. Medical Anthropology. doi:10.1080/01459740.2020.1808976.
  • Barry, A. 2005 Pharmaceutical matters: The invention of informed materials. Theory, Culture & Society 22(1):51–69. doi:10.1177/0263276405048433.
  • Blanchard, A., and R. Strand 2017 Cancer Biomarkers: Ethics, Economics and Society. Kokstad, Sweden: Megaloceros Press.
  • Boland, C. R., and A. Goel 2010 Microsatellite instability. Colorectal Cancer Gastroenterology 138(6): 2073–2087
  • Bonneville, R., M. A. Krook, E. A. Kautto, J. Miya, M. R. Wing, H. Z. Chen, and S. Roychowdhury 2017 Landscape of microsatellite instability across 39 cancer types. JCO Precision Oncology 1:1–15. doi:10.1200/PO.17.00073.
  • Bourret, P., and A. Cambrosio 2019 Genomic expertise in action: Molecular tumour boards and decision‐making in precision oncology. Sociology of Health & Illness 41(8):1568–84. doi:10.1111/1467-9566.12970.
  • Boyle, J., M. Braun, E. Eaves, J. Hill, A. Kuryba, A. Roe, and K. Walker 2017 National bowel cancer audit: Annual report 2017. London: Healthcare Quality Improvement Partnership. https://www.nboca.org.uk/reports/2017-annual-report/, Accessed December 2 2019.
  • Cancer Research UK 2014 Bowel cancer survival statistics. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer/survival#ref-2
  • Charlesworth, A., and P. Johnson 2018 Securing the future: Funding health and social care to the 2030s. Study developed by The Institute of Fiscal Studies and the Health Foundation. Uckfeld, UK: Pureprint Group.
  • Day, S., R. C. Coombes, L. McGrath-Lone, C. Schoenborn, and H. Ward 2017 Stratified, precision or personalized medicine? Cancer Services in the “Real World” of a London Hospital. Sociology of Health & Illness 39(1):143–58. doi:10.1111/1467-9566.12457.
  • Dudley, J. C., M. T. Lin, D. T. Le, and J. R. Eshleman 2016 Microsatellite instability as a biomarker for PD-1 blockade. Clinical Cancer Research 22(4):813–20. doi:10.1158/1078-0432.CCR-15-1678.
  • Funtowicz, S., and J. Ravetz 1993 Science for the post-normal age. Futures 31(7):735–55.
  • Good, B. J. 1993 Medicine, Rationality and Experience: An Anthropological Perspective. Cambridge, UK: Cambridge University Press.
  • Hardon, A., and E. Sanabria 2017 Fluid drugs: Revisiting the anthropology of pharmaceuticals. Annual Review of Anthropology 46:117–32. doi:10.1146/annurev-anthro-102116-041539.
  • Hastrup, K. 2004 Getting it right: Knowledge and evidence in anthropology. Anthropological Theory 4(4):455–72. doi:10.1177/1463499604047921.
  • Hedgecoe, A., and P. Martin 2008 Genomics, STS, and the making of sociotechnical futures. In Handbook of Science and Technology Studies J. Hackett, E. Amsterdamska, O. Lynch, and M. Wajcman, eds., Pp. 817–42. Boston, MA: MIT University Press.
  • Jain, L. 2007 Living in prognosis: Toward an elegiac politics. Representations 98(1):77–92. doi:10.1525/rep.2007.98.1.77.
  • Kaufman, S. R. 2015 Ordinary Medicine: Extraordinary Treatments, Longer Lives, and Where to Draw the Line. Durham, NC: Duke University Press.
  • Keating, P., and A. Cambrosio 2011 Cancer on Trial: Oncology as a New Style of Practice. Chicago, IL: University of Chicago Press.
  • Kerr, A., J. Swallow, C. K. Chekar, and S. Cunningham-Burley 2019 Genomic research and the cancer clinic: Uncertainty and expectations in professional accounts. New Genetics and Society 38(2):1–18. doi:10.1080/14636778.2019.1586525.
  • Kerr, A., and S. Cunningham-Burley 2015 Embodied innovation and regulation of medical technoscience: Transformations in cancer patienthood. Law, Innovation and Technology 7(2):187–205.
  • Krueger, G. M. 2008 Hope and Suffering: Children, Cancer, and the Paradox of Experimental Medicine. Baltimore, MD: Johns Hopkins University Press.
  • Le, D., J. N. Uram, H. Wang, B. R. Bartlett, H. Kemberling, A. D. Eyring, and B. Biedrzycki 2015 PD-1 blockade in tumors with mismatch-repair deficiency. New England Journal of Medicine 372(26):2509–20. doi:10.1056/NEJMoa1500596.
  • Marmot, M., J. Allen, J. T. Boyce, P. Goldblatt, and J. Morrison 2020 Health Equity in England: The Marmot Review 10 Years On. London: Institute of Health Equity.
  • McGrath-Lone, L., S. Day, S., C. Schoenborn, and H. Ward 2015 Exploring research participation among cancer patients: Analysis of a national survey and an in-depth interview study. BMC Cancer 15:618. doi:10.1186/s12885-015-1628-8.
  • Myers, N. 2015 Rendering Life Molecular: Models, Modelers, and Excitable Matter. Durham, NC: Duke University Press.
  • Nading, A. 2017 Local biologies. Leaky Things, and the Chemical Infrastructure of Global Health. Medical Anthropology 36(2):141–56.
  • Nuffield Council on Bioethics. 2003 Pharmacogenetics: Ethical Issues. London: The Dorset Press.
  • Ong, A. 2016 Fungible Life: Experiment in the Asian City of Life. Durham, NC: Duke University Press.
  • Prainsack, B. 2017 Personalized Medicine: Empowered Patients in the 21st Century? New York: New York University Press.
  • Rose, N. 2013 Personalized medicine: Promises, problem and perils of a new paradigm for healthcare. Procedia – Social and Behavioral Sciences 77:341–52. doi:10.1016/j.sbspro.2013.03.092.
  • Sanz, C. 2017 Out-of-sync cancer care: Health insurance companies. Biomedical Practices, and Clinical Time in Colombia. Medical Anthropology 36(3):187–201.
  • Stage, C. 2017 Networked Cancer: Affect, Narrative and Measurement. Cham, Switzerland: Palgrave Macmillan.
  • Taussig, K., K. Hoeyer, and S. Helmreich 2013 The Anthropology of potentiality in biomedicine: An introduction to Supplement 7. Current Anthropology 54(S7):3–14. doi:10.1086/671401.
  • Timmermann, C., and E. Toon 2012 Running Out of Options. Cancer Patients, Cancer Pathways. Basingtoke, UK: Palgrave Macmillan.
  • Tutton, R. 2014 Genomics and the Reimagining of Personalized Medicine. London: Routledge.
  • Wahlberg, A., and N. Rose 2015 The governmentalization of living: Calculating global health. Economy and Society 44(1):60–90. doi:10.1080/03085147.2014.983830.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.